Press releases

These press releases are intended for business journalists and analysts/investors

GSK Institute for Infectious Diseases and Public Health to partner with Tsinghua University to tackle global public health challenges

GSK today announced a Memorandum of Understanding Agreement between the GSK Institute for Infectious Diseases and Public Health and Tsinghua University School of Medicine (Tsinghua). This 5 year public-private partnership will take on public health challenges in China and globally through scientific and talent exchange as well as joint research programs.

Read more - GSK Institute for Infectious Diseases and Public Health to partner with Tsinghua University to tackle global public health challenges Read more

GSK China committed to making newly launched treatment Tivicay® accessible to Chinese people living with HIV

GSK China recently marked the official launch of Tivicay® (dolutegravir), an innovative HIV drug from ViiV Healthcare1, and will continue to work with relevant Chinese government agencies to make it more accessible to people living with HIV in China by its inclusion in China’s free antiretroviral (ARV) programme. On 30 December 2015, Tivicay received approval from the China Food and Drug Administration (CFDA) for use in combination with other anti-retroviral medicinal products for the treatment of HIV infected adults and adolescents above 12 years of age.

Read more - GSK China committed to making newly launched treatment Tivicay® accessible to Chinese people living with HIV Read more

GSK reduces price for its first line treatment for chronic hepatitis B

GSK China today committed to reduce the price of its first-line chronic hepatitis B (CHB) treatment, patent-protected Viread® (tenofovir disoproxil fumarate)1, in China by up to 67%. This follows an announcement on the outcomes of a national price negotiation pilot by the National Health and Family Planning Commission (NHFPC) and other relevant government agencies.

Read more - GSK reduces price for its first line treatment for chronic hepatitis B Read more